GOLDENWELL BIOTECH, INC. (GWLL)
About GOLDENWELL BIOTECH, INC.
GOLDENWELL BIOTECH INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $139
- Net income
- -$131.5K
- Total assets
- $224.2K
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Goldenwell Biotech, Inc. (GWLL) Stock Price
- Reported a net loss of $131.5K in FY2024.
- Trading 87% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review GOLDENWELL BIOTECH, INC..
Write a review
Goldenwell Biotech, Inc.: frequently asked questions
Is Goldenwell Biotech, Inc. an American company?
Goldenwell Biotech, Inc. is a US-based company headquartered in Solon, Ohio, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Goldenwell Biotech, Inc. headquartered?
Goldenwell Biotech, Inc. is headquartered in Solon, Ohio, United States.
Is Goldenwell Biotech, Inc. publicly traded?
Yes — Goldenwell Biotech, Inc. is a publicly traded company. Its stock trades under the ticker symbol GWLL on the OTC.
What does Goldenwell Biotech, Inc. do?
Goldenwell Biotech, Inc. is an American Meat & Seafood company in the Food & Beverage sector.
